Filmecc Co., Ltd. appears in FDA records as the applicant on a single premarket notification in the supplied collection, K261281, decided Substantially Equivalent on 2026-09-03. The submission covers CROSSLEAD Standard 035 and CROSSLEAD Stiff 035, classified under 21 CFR 870.1330 as a guide-catheter wire in the cardiovascular panel. Filmecc's own site places the firm within the ASAHI INTECC Group and lists medical devices, medical components and industrial components as its lines of business. [1][3][4]

The K261281 clearance and its scope

K261281 was received 2026-04-17 and decided 2026-09-03 with decision code SESE, described as Substantially Equivalent. The record lists product code DQX, regulation 870.1330, device class 2, advisory committee CV, Traditional clearance type, no third-party review, and a Summary as the statement or summary type. The applicant contact is Hayato Tsuboi at 3-99 Akatsuki-Cho, Seto-Shi, Japan. [1][4]

A separate index of the same submission reports the indications for use as directing a catheter to the desired anatomical location in the peripheral vasculature during diagnostic or interventional procedures, with peripheral vascular use only. That wording is attributed to the indexing publisher, not to Filmecc. [6][7]

Documented products and technology

The cleared device names are CROSSLEAD Standard 035 and CROSSLEAD Stiff 035, both filed under product code DQX. Filmecc's US-facing site describes custom-made flexible ultra-fine wire ropes and tubing with high torsional rigidity for minimally invasive medical devices, and lists wire drawing, wire forming and torque among its core technologies. [1][8]

Filmecc's corporate site lists medical devices, medical components and industrial components as business categories, with wire coil among the industrial component products. The site states that FILMEC contributes to society as a member of the ASAHI INTECC Group, which is the only group relationship the sources explicitly verify. [3]

Applicant identity versus group and brand

FDA records name Filmecc Co., Ltd. as the applicant on K261281, and a third-party index of company filings lists earlier DQX submissions under the same applicant name, including VASSALLO GT Hybrid in 2021 and VASSALLO GT 018 variants in 2022 and 2023. Those entries appear in the index only and are not part of the supplied record sample. [4][9]

Filmecc USA, Inc. appears on Filmecc's global presence page as a sales office in Tustin, California, and publishes its own product and technology pages. The sources do not state that Filmecc USA is the legal applicant for any clearance, so applicant status stays with Filmecc Co., Ltd. [5][8]

What the supplied filings do and do not show

The supplied collection contains one linked 510(k) record, K261281, with one SESE decision; the record sample is the same single entry. These counts describe the supplied filings as of the snapshot date and are not measures of total company sales, total portfolio or safety performance. [1]

A registration listing ties K261281 to Filmecc Co., Ltd. at the Seto-shi, Aichi address and shows product code DQX with eight registration listing records and a latest decision of 2026-09-03. The sources do not document manufacturing sites, certifications, customers or commercial availability for the CROSSLEAD devices. [9]